Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX®

NCT01500122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Formulation Finding

Interventions

DRUG: RhuDex

Sponsor

MediGene